GE Healthcare, a unit of General Electric Company, said it received U.S. Food and Drug Administration (FDA) approval for its new mammography platform. The Senographe(R) Essential is the next-generation of GE's Senographe Full Field Digital Mammography system. With a 24 cm by 31 cm detector size, the Senographe Essential reportedly offers the largest active field of view in the industry. The foundation of the Senographe Essential imaging is GE's digital detector, which at low doses is said to deliver the industry's highest Detective Quantum Efficiency (DQE), said to be the new standard for quantifying digital X-ray image quality.
The new Senographe Essential is the latest addition to the GE Healthcare Senographe family of products. Introduced in early 2004, the Senographe DS was the first and only full-field digital mammography system designed to meet all the clinical needs from screening to diagnostic to interventional procedures, using the same detector to optimize image quality and workflow.
The GE's Senographe system is designed to offer better visibility of the breast, particularly near the skin line, the chest wall and in women with dense breast tissue. The system is designed to reduce exam time by as much as half, due to the fast signal readout of GE's detector design, the ability to rapidly generate images and the optimized, highly automated digital workflow.
The system is said to result in fewer patient callbacks. The flexibility to magnify and manipulate digital images to provide more clinically relevant information I said to help eliminate some callbacks that are necessary with traditional film-based mammography systems. The system benefits from telemedicine advancements, which allow breast images to be sent anywhere in the world electronically and be reviewed on a computer. Electronic archival of patient images means easier retrieval and transmission of patient information to healthcare providers.
to Daily News